NDC 70748-299
ATOVAQUONE
Atovaquone
ATOVAQUONE is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Atovaquone.
| Product ID | 70748-299_26a9360d-7db4-42fe-b9d2-ecddfe369d2e |
| NDC | 70748-299 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ATOVAQUONE |
| Generic Name | Atovaquone |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-06-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA210692 |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Substance Name | ATOVAQUONE |
| Active Ingredient Strength | 750 mg/5mL |
| Pharm Classes | Antimalarial [EPC],Antiprotozoal [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |